ARCHIVES

An old drug’s 21st century makeover begins with 84-fold price increase. Price hike of procarbazine astonishes brain tumor specialists.

This article is from The Cancer Letter archive.

Vol. 31 No. 19 | May 13, 2005

Download PDF Visit The Full Archive

Related Articles

Leyland-Jones Named Director of Emory’s Winship Cancer Institute

November 17, 2006

Neuro-Oncologist Schold Leaves Duke For UPCI; Rosner Leads Institute At Chicago.

September 1, 2000

Tobacco Control and Prevention Saved 795,000 Lives Between 1975-2000, Study Shows

March 30, 2012

CIS Cost Sharing Feasibility Study Recommended

December 11, 1987

SWOG Launching New Study Based on Recurrence Test Scores

April 29, 2011

ACS Finds 1 In 4 US Deaths From Cancer; Weiss Named NCI Centers Branch Chief.

January 18, 2002